Powered by ZigaForm version 3.9.8.8

Director General’s PageMeet The Director General, NAFDAC

Prof. Moji Christianah Adeyeye
Prof. Moji Christianah Adeyeye

Professor Adeyeye is the Director General (DG) of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) where she is leading regulatory and administrative reforms through quality management approach. She has added strong governance structure and regulatory strengthening to NAFDAC through disciplined and motivating workforce, updating of regulations and guidelines, strengthening the local pharmaceutical companies through international best practices and encouraging local production. She has brought NAFDAC from insolvency to solvency and refocused the Agency to be Standard Operating Procedure-driven organization that has embraced international standards and best practices. She changed the culture of NAFDAC to Customer-focused and Agency-minded establishment in order to safeguard the health of the nation.  She inaugurated Nigerian Herbal Medicine Product Committee (HMPC) as a means of fostering research involving herbal practitioners and academic researchers while the intellectual property is protected. The ultimate goal is to turn complementary alternative medicines into a research-driven, regulation controlled commercially viable commodities.

She currently serves as the Chair of the Steering Committee of the African Medicines Regulatory Harmonization (AMRH) and the WHO-based Global Pediatric Regulatory Network. She represents NAFDAC on the International Coalition of Medicines Regulatory Authorities (ICMRA) and has been invited to be on the WHO Regional Expert Advisory Committee on Traditional Medicine for COVID-19.   She is a Fellow of Nigeria Academy of Science, Nigeria Academy of Pharmacy, an Academic Research Fellow of American Association of Colleges of Pharmacy (AACP). She is the First African Woman Fellow, American Association of Pharmaceutical Scientists (AAPS) a society where only 3% of academia receives such recognition internationally.

She is Professor Emeritus of Pharmaceutics and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, USA.  Professor Adeyeye was the founding Chair of Biopharmaceutical Sciences at the same University in Illinois. She was Professor of Pharmaceutics and Manufacturing for twenty-one (21) years at Duquesne University in Pittsburgh, PA, USA.   She is a Senior Fulbright Scholar and Specialist. She earned her B.S from the University of Nigeria, Nsukka, Nigeria and MS and PhD from the University of Georgia, Athens, GA. Her research interests include quality-by-design (QbD) early phase development and manufacturing of solid, semisolid and liquid dosage forms, including Investigation New Drug Application (IND)-based late phase manufacturing.  She is an expert in research and drug development (R&D), bench-to-bedside translational research and regulatory science. She has mentored over 15 PhD and M.S candidates. She has 5 patents, 65 peer reviewed manuscripts, book chapters and books, and more than 140 scientific presentations.  

Was this post helpful?